Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Confirmatory study of EN-P09 in patients with enteral tube feeding via gastrostomy
jRCT2031210285Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Sep 2021
- Countries
- 1
01
Overview
Trial of Innosolid (2 arms), sponsored by Otsuka Pharmaceutical Co., Ltd. Primary endpoints: Transthyretin, Retinol-binding protein and 1 more. Started Sep 2021; status: completed.
02
Drugs
Innosolid
Beyond the preview
Go deeper on jRCT2031210285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031210285.